164 related articles for article (PubMed ID: 38809874)
21. [Cannabinoid hyperemesis as a differential diagnosis of nausea and vomiting in the emergency department].
Korn F; Hammerich S; Gries A
Anaesthesist; 2021 Feb; 70(2):158-160. PubMed ID: 33090239
[TBL] [Abstract][Full Text] [Related]
22. Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: An interrupted time series study.
Kim C; Chum A; Nielsen A; Allin S; Penney TL; Rittenbach K; MacMaster FP; O'Campo P
PLoS One; 2022; 17(10):e0268718. PubMed ID: 36288275
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid hyperemesis syndrome in pregnancy: Challenges and opportunities.
Kirby J; Naren T
Aust N Z J Obstet Gynaecol; 2023 Dec; 63(6):746-752. PubMed ID: 37259610
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
Richards JR
J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid Hyperemesis Syndrome: Lighting Up an Emergency Department Near You.
Camcejo M; Hillman E; Isom H
Mo Med; 2022; 119(3):266-270. PubMed ID: 36035580
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid hyperemesis syndrome.
Galli JA; Sawaya RA; Friedenberg FK
Curr Drug Abuse Rev; 2011 Dec; 4(4):241-9. PubMed ID: 22150623
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid hyperemesis syndrome: a review of the literature.
Deceuninck E; Jacques D
Psychiatr Danub; 2019 Sep; 31(Suppl 3):390-394. PubMed ID: 31488758
[TBL] [Abstract][Full Text] [Related]
28. Cannabis positivity rates in 17 emergency departments across the United States with varying degrees of marijuana legalization.
Tolan NV; Krasowski MD; Mathias PC; Wiencek JR; Babic N; Chai PR; Chambliss AB; Choucair I; Demetriou CA; Erickson TB; Feldhammer M; French D; Hayes BD; Kang P; El-Khoury JM; Knezevic CE; Monte A; Nerenz RD; Okorodudu AO; Roper SM; Saitman A; Thiriveedhi V; Uljon SN; Vest A; Woodworth A; Yu M; Melanson SEF
Clin Toxicol (Phila); 2023 Apr; 61(4):248-259. PubMed ID: 37129223
[TBL] [Abstract][Full Text] [Related]
29. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
Hickey JL; Witsil JC; Mycyk MB
Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology.
Iacopetti CL; Packer CD
Clin Med Res; 2014 Sep; 12(1-2):65-7. PubMed ID: 24667219
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing and treating cannabinoid hyperemesis.
Wilson O; Lutton S; Doherty K
Emerg Nurse; 2015 Dec; 23(8):22-5. PubMed ID: 26638755
[TBL] [Abstract][Full Text] [Related]
32. Emergency Department Pediatric Visits in Alberta for Cannabis After Legalization.
Yeung MEM; Weaver CG; Hartmann R; Haines-Saah R; Lang E
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34544846
[TBL] [Abstract][Full Text] [Related]
33. Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013.
Bollom A; Austrie J; Hirsch W; Nee J; Friedlander D; Iturrino J; Ballou S; Lembo A
J Clin Gastroenterol; 2018 Oct; 52(9):778-783. PubMed ID: 29095419
[TBL] [Abstract][Full Text] [Related]
34. Trends and associated factors of use of opioid, heroin, and cannabis among patients for emergency department visits in Nevada: 2009-2017.
Kim PC; Yoo JW; Cochran CR; Park SM; Chun S; Lee YJ; Shen JJ
Medicine (Baltimore); 2019 Nov; 98(47):e17739. PubMed ID: 31764772
[TBL] [Abstract][Full Text] [Related]
35. SAEM GRACE: Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome in the emergency department: A systematic review of direct evidence.
Sabbineni M; Scott W; Punia K; Manuja K; Singh A; Campbell K; MacKillop J; Balodis I
Acad Emerg Med; 2024 May; 31(5):493-503. PubMed ID: 37391387
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem.
Dosani K; Koletic C; Alhosh R
Pediatr Rev; 2021 Sep; 42(9):500-506. PubMed ID: 34470869
[TBL] [Abstract][Full Text] [Related]
37. Marijuana Use: Early Recognition for a Cannabinoid Hyperemesis Syndrome.
Abrams T; Gantioque R
Adv Emerg Nurs J; 2020; 42(1):30-36. PubMed ID: 32000189
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice.
Kast KA; Gershengoren L
J Psychiatr Pract; 2018 Jan; 24(1):51-55. PubMed ID: 29320384
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
Nourbakhsh M; Miller A; Gofton J; Jones G; Adeagbo B
J Forensic Sci; 2019 Jan; 64(1):270-274. PubMed ID: 29768651
[TBL] [Abstract][Full Text] [Related]
40. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure.
Argamany JR; Reveles KR; Duhon B
Am J Emerg Med; 2016 Apr; 34(4):765.e1-2. PubMed ID: 26422191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
